Camp RL - Search Results

1

Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.

Kidd M, Eick G, Shapiro MD, Camp RL, Mane SM, Modlin IM. Kidd M, et al. Among authors: camp rl. Cancer. 2005 Jan 15;103(2):229-36. doi: 10.1002/cncr.20750. Cancer. 2005. PMID: 15599934 Free article.

2

Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1.

Kidd M, Modlin IM, Pfragner R, Eick GN, Champaneria MC, Chan AK, Camp RL, Mane SM. Kidd M, et al. Among authors: camp rl. Cancer. 2007 Jun 15;109(12):2420-31. doi: 10.1002/cncr.22725. Cancer. 2007. PMID: 17469181 Free article.

3

Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning.

Drozdov I, Kidd M, Nadler B, Camp RL, Mane SM, Hauso O, Gustafsson BI, Modlin IM. Drozdov I, et al. Among authors: camp rl. Cancer. 2009 Apr 15;115(8):1638-50. doi: 10.1002/cncr.24180. Cancer. 2009. PMID: 19197975 Free PMC article.

4

The role of genetic markers--NAP1L1, MAGE-D2, and MTA1--in defining small-intestinal carcinoid neoplasia.

Kidd M, Modlin IM, Mane SM, Camp RL, Eick G, Latich I. Kidd M, et al. Among authors: camp rl. Ann Surg Oncol. 2006 Feb;13(2):253-62. doi: 10.1245/ASO.2006.12.011. Epub 2006 Jan 20. Ann Surg Oncol. 2006. PMID: 16424981

5

Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease.

Kidd M, Modlin IM, Mane SM, Camp RL, Shapiro MD. Kidd M, et al. Among authors: camp rl. Ann Surg. 2006 Feb;243(2):273-80. doi: 10.1097/01.sla.0000197734.28551.0f. Ann Surg. 2006. PMID: 16432362 Free PMC article.

6

Utility of molecular genetic signatures in the delineation of gastric neoplasia.

Kidd M, Modlin IM, Mane SM, Camp RL, Eick GN, Latich I, Zikusoka MN. Kidd M, et al. Among authors: camp rl. Cancer. 2006 Apr 1;106(7):1480-8. doi: 10.1002/cncr.21758. Cancer. 2006. PMID: 16502410 Free article.

7

Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed.

Modlin IM, Kidd M, Latich I, Zikusoka MN, Eick GN, Mane SM, Camp RL. Modlin IM, et al. Among authors: camp rl. Ann Surg. 2006 Jul;244(1):52-60. doi: 10.1097/01.sla.0000217617.06782.d5. Ann Surg. 2006. PMID: 16794389 Free PMC article.

8

Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.

Chung GG, Yoon HH, Zerkowski MP, Ghosh S, Thomas L, Harigopal M, Charette LA, Salem RR, Camp RL, Rimm DL, Burtness BA. Chung GG, et al. Among authors: camp rl. Cancer. 2006 Apr 15;106(8):1677-84. doi: 10.1002/cncr.21783. Cancer. 2006. PMID: 16532435 Free article.

9

Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.

Tolgay Ocal I, Dolled-Filhart M, D'Aquila TG, Camp RL, Rimm DL. Tolgay Ocal I, et al. Among authors: camp rl. Cancer. 2003 Apr 15;97(8):1841-8. doi: 10.1002/cncr.11335. Cancer. 2003. PMID: 12673709 Free article.

10

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.

Camp RL, Rimm EB, Rimm DL. Camp RL, et al. Cancer. 1999 Dec 1;86(11):2259-65. doi: 10.1002/(sici)1097-0142(19991201)86:11<2259::aid-cncr13>3.0.co;2-2. Cancer. 1999. PMID: 10590366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters